Table 2. Mode of Diagnosis (Mostly by White Light Cystoscopy), Stage at Presentation and Histological Types.
| Study | Mode of diagnosis | Tumor stage at presentation | Histopathological type of bladder cancer |
||
|---|---|---|---|---|---|
| Urothelial cancer | Squamous cell | Others | |||
| Nour et al [16] | Cystoscopy | NMIBC | |||
| Ochicha et al [13] | N/A | N/A | 35% (18/51) | 53% (27/51) | 12% (6/51) |
| Diao et al[17] | Cystoscopy | N/A | N/A | 50.7% | 29.2% Schistosoma ova |
| Takure et al [18] | N/A | N/A | 68.5% (122/181) | 19.9% | 11% Adenocarcinoma |
| Sule et al [19] | 40.6% NMIBC | 49.6% | 44.3% | 6.1% | |
| Forae et al [7] | 70.% NMIBC | 64.7% | 5.9% | 29.4% | |
| Avakoudjo et al [20] | Cystoscopy | N/A | N/A | 1 patient | 3 Adenocarcinomas |
| Samake et al [21] | Cystoscopy | N/A | 20% | 76% | 4% |
| Mapulanga et al [12] | N/A | 30.2% | 60.4% | 9.4 % Adenocarcinoma | |
| Ibrahim et al [22] | Cystoscopy | N/A | 30.5% | 63.8% | 5.7% |
| Sharif-Askari et al [23] | Cystoscopy | N/A | 87.4% | 8.9% | 3.7% |
| Biluts et al [8] | Cystoscopy | 85.5% NMIBC | 80.4% | 5,2% | 3.1% Adenocarcinoma |
| Rambau et al [15] | 35.1% NMIBC | 40.5% | 55.1% | 4.4% | |
NMIBC: non-muscle invasive bladder cancer.